← Back to Clinical Trials
Recruiting NCT03715517

NCT03715517 Spinal Anesthesia For Enhanced Recovery After Liver Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03715517
Status Recruiting
Phase
Sponsor University of Manitoba
Condition Hepatectomy
Study Type INTERVENTIONAL
Enrollment 128 participants
Start Date 2018-10-04
Primary Completion 2031-07-31

Trial Parameters

Condition Hepatectomy
Sponsor University of Manitoba
Study Type INTERVENTIONAL
Phase N/A
Enrollment 128
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2018-10-04
Completion 2031-07-31
Interventions
Continuous thoracic epidural analgesiaSpinal anesthesia with intrathecal morphineBupivacaine 0.75% in Dextrose Inj 8.25%

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This project proposes to compare epidural versus spinal anesthesia in patients having liver resection surgery. The investigators hypothesize that spinal anesthesia will result in improved blood pressure control postoperatively and reduce the amount of intravenous fluids required after surgery. Spinal anesthesia is expected to provide the same pain control benefits as epidurals, with faster recovery of function. Spinal anesthesia may be a simple and effective way to improve and enhance the recovery in the increasing number of patients requiring liver resection.

Eligibility Criteria

Inclusion Criteria: * Male or female, Adults aged ≥ 18 years (there will be no upper age restriction); * American Society of Anesthesiologists Physical Status classification (ASA-PS) of I to III; * Undergoing subcostal or midline laparotomy for elective liver resection surgery under general anesthesia; if the planned procedure is a combined operation (i.e., concomitant extrahepatic surgery) , the associated procedure should not add more than one hour to the surgical time of the primary hepatic resection procedure alone; * Stated willingness to comply with all study procedures and availability for the duration of the study * Provision of signed and dated informed consent form * Body mass index (BMI) between 17 and 40 kg·m-², inclusive; * Negative result on serum pregnancy test at Screening and negative urine pregnancy test at Baseline (for women of childbearing potential, defined as those who have not undergone a hysterectomy or been postmenopausal for at least 12 consecutive months); a

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology